Dashboard
Manage Tickers

CVMCEL SCI CORP

NYSE cel-sci.com


$ 1.50 $ 0.12 (8.63 %)    

Thursday, 09-May-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 1.51
$ 1.53
$ 0.00 x 0
$ 0.00 x 0
$ 1.44 - $ 1.53
$ 1.04 - $ 3.23
636,116
na
75.66M
$ 0.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-14-2024 12-31-2023 10-Q
2 12-21-2023 09-30-2023 10-K
3 08-10-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 02-14-2023 12-31-2022 10-Q
6 12-27-2022 09-30-2022 10-K
7 08-12-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 02-11-2022 12-31-2021 10-Q
10 12-21-2021 09-30-2021 10-K
11 08-13-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 02-12-2021 12-31-2020 10-Q
14 12-29-2020 09-30-2020 10-K
15 08-10-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 02-10-2020 12-31-2019 10-Q
18 12-16-2019 09-30-2019 10-K
19 08-14-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 02-14-2019 12-31-2018 10-Q
22 12-19-2018 09-30-2018 10-K
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 02-12-2018 12-31-2017 10-Q
26 12-29-2017 09-30-2017 10-K
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 02-09-2017 12-31-2016 10-Q
30 12-14-2016 09-30-2016 10-K
31 08-09-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 02-09-2016 12-31-2015 10-Q
34 12-11-2015 09-30-2015 10-K
35 08-07-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 02-06-2015 12-31-2014 10-Q
38 12-23-2014 09-30-2014 10-K
39 08-08-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

why-cel-sci-cvm-shares-are-trading-higher
Why CEL-SCI (CVM) Shares Are Trading Higher
05/08/2024 15:19:20

CEL-SCI shares are trading higher by 18.6% during Wednesday's session. The company received positive feedback from the FDA ...

cel-sci-shares-are-trading-higher-after-the-company-announced-it-received-fda-approval-for-its-confirmatory-study-of-multikine-for-the-treatment-of-head--neck-cancer
CEL-SCI shares are trading higher after th...
05/08/2024 15:19:02

cel-sci-receives-fda-approval-for-its-confirmatory-study-of-multikine-for-the-treatment-of-head--neck-cancer
CEL-SCI Receives FDA Approval For Its Conf...
05/08/2024 13:03:58

Critical milestone achieved—the FDA accepted CEL-SCI's selection criteria defining the Multikine target population before s...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 12:06:34

cel-sci-corporation-issues-letter-to-shareholders
CEL-SCI Corporation Issues Letter To Share...
03/06/2024 13:47:33

CEL-SCI Corporation (NYSE:CVM) today issued a letter to its shareholders. This letter will be sent to the Company's shareho...

cel-sci-q1-eps-014-up-from-018-yoy
CEL-SCI Q1 EPS $(0.14) Up From $(0.18) YoY
02/15/2024 13:12:43

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.14) per share. This is a 22.22 percent increase over losses of $(0.18) per ...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
02/09/2024 17:31:35

why-cel-sci-corporation-cvm-shares-are-diving
Why CEL-SCI Corporation (CVM) Shares Are D...
02/09/2024 16:06:50

CEL-SCI Corporation shares are trading lower by 13.9% Friday morning. The company priced an offering of 3.875 million shares.

cel-sci-announces-pricing-of-775m-public-offering-of-3875m-shares-of-common-stock-at-200share
CEL-SCI Announces Pricing Of $7.75M Public...
02/09/2024 13:32:32

european-medicines-agency-grants-cel-sci-a-waiver-of-strict-pediatric-requirements-clearing-the-path-towards-marketing-authorization-for-multikine
European Medicines Agency Grants CEL-SCI A...
01/31/2024 14:18:40

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
12/28/2023 21:31:10

cel-sci-clocks-fy23-eps-loss-of-073-vs-087-yoy-operating-loss-of-315m-vs-361m-yoy
CEL-SCI Clocks FY23 EPS Loss of $(0.73) Vs...
12/22/2023 13:04:56

why-u-power-shares-are-trading-lower-by-around-54-here-are-other-stocks-moving-in-mondays-mid-day-session
Why U Power Shares Are Trading Lower By Ar...
12/04/2023 18:10:23

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of reg...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/04/2023 17:31:02

why-is-cancer-focused-cel-sci-stock-trading-higher-today
Why Is Cancer Focused CEL-SCI Stock Tradin...
12/04/2023 16:45:52

CEL-SCI Corporation (AMEX: CVM) announced that the British National Institute for Health and Care Excellence (NICE) has selecte...

uks-national-institute-for-health-and-care-excellence-selects-cel-scis-multikine-as-potential-new-standard-of-care-for-head--neck-cancer
UK'S National Institute for Health And Car...
12/04/2023 13:38:14

CEL-SCI Corporation (NYSE:CVM) today announced that the British National Institute for Health and Care Excellence (NICE) has se...

cel-sci-prices-249m-share-offering-to-a-single-investor-at-offering-price-of-2share
CEL-SCI Prices 2.49M Share Offering To A S...
11/16/2023 13:35:08

cel-sci-issues-letter-to-shareholders
CEL-SCI Issues Letter To Shareholders
10/30/2023 13:20:59

CEL-SCI Corporation (NYSE:CVM) today released a letter to shareholders from the Company's CEO, Geert Kersten. The very comp...

cel-sci-releases-video-detailing-recent-phase-3-findings--its-plans-to-seek-immediate-regulatory-approvals
CEL-SCI Releases Video Detailing Recent Ph...
10/24/2023 12:21:19

CEL-SCI Corporation (NYSE:CVM) today released a video presentation in which the Company's CEO, Geert Kersten, shares the mo...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION